SB-366791

SB-366791
Identifiers
	IUPAC name (E)-3-(4-chlorophenyl)-N-(3-methoxyphenyl)prop-2-enamide;
CAS Number	472981-92-3 ;
PubChem CID	667594;
ChemSpider	580962;
UNII	E8EY4M2N4H;
ChEBI	CHEBI:93038;
ChEMBL	ChEMBL122413;
Chemical and physical data
Formula	C16H14ClNO2
Molar mass	287.74 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=CC=CC(=C1)NC(=O)/C=C/C2=CC=C(C=C2)Cl;
	InChI InChI=1S/C16H14ClNO2/c1-20-15-4-2-3-14(11-15)18-16(19)10-7-12-5-8-13(17)9-6-12/h2-11H,1H3,(H,18,19)/b10-7+; Key:RYAMDQKWNKKFHD-JXMROGBWSA-N;

SB-366791 is a drug which acts as a potent and selective blocker of the TRPV1 ion channel. It has analgesic effects in animal studies, and is used in research into pain and inflammation.^[1]^[2]^[3]

References

↑ Dell H (December 2003). "New compound fires up pain research". Drug Discovery Today. 8 (23): 1053. doi:10.1016/s1359-6446(03)02928-3. PMID 14693457.
↑ Ma SX, Kim HC, Lee SY, Jang CG (December 2018). "TRPV1 modulates morphine self-administration via activation of the CaMKII-CREB pathway in the nucleus accumbens". Neurochemistry International. 121: 1–7. doi:10.1016/j.neuint.2018.10.009. PMID 30292787. S2CID 52929149.
↑ Uchytilova E, Spicarova D, Palecek J (April 2021). "Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist". International Journal of Molecular Sciences. 22 (7): 3712. doi:10.3390/ijms22073712. PMC 8038144. PMID 33918267.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Dell H (December 2003). "New compound fires up pain research". Drug Discovery Today. 8 (23): 1053. doi:10.1016/s1359-6446(03)02928-3. PMID 14693457.

[2] Ma SX, Kim HC, Lee SY, Jang CG (December 2018). "TRPV1 modulates morphine self-administration via activation of the CaMKII-CREB pathway in the nucleus accumbens". Neurochemistry International. 121: 1–7. doi:10.1016/j.neuint.2018.10.009. PMID 30292787. S2CID 52929149.

[3] Uchytilova E, Spicarova D, Palecek J (April 2021). "Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist". International Journal of Molecular Sciences. 22 (7): 3712. doi:10.3390/ijms22073712. PMC 8038144. PMID 33918267.

[1]

[2]

[3]

See also

References